Tenecteplase for ischemic stroke: a treatment registry
Part of Brain & nervous system, Heart & circulation clinical trials.
This study collects information from people who have had an ischemic stroke (a stroke caused by a blocked blood vessel in the brain) and were treated with the clot-busting drug tenecteplase. The goal is to learn more about how well this treatment works in everyday practice and how safe it is, which can help improve stroke care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You had a stroke caused by a blocked artery (ischemic stroke), confirmed by a CT or MRI scan
- You received the clot-busting medicine tenecteplase within 4.5 hours of your symptoms starting, or within a longer window if special imaging showed you could benefit, or you had a wake-up stroke
- You did not receive a different clot-busting medicine called alteplase instead of tenecteplase
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a clot-busting drug called tenecteplase for people having a disabling ischemic stroke (a clot blocking blood flow to the brain). It aims to see if the drug can help improve recovery when given within 4.5 hours of symptoms starting.
This trial studies the use of a clot-busting medicine called tenecteplase given more than 4.5 hours after a stroke starts. It aims to see if this treatment can help people who wake up with stroke symptoms or whose stroke time is unknown.
This study tests a clot-dissolving drug called tenecteplase given directly into the artery after a mechanical thrombectomy (clot removal). The goal is to see if it helps improve blood flow to the small vessels in the brain after the main clot is removed.
This trial tests a clot-dissolving medicine called tenecteplase for people who had a stroke more than 4.5 hours ago. It may help you recover if given later than usual.
This study is collecting information on stroke patients who received the clot-dissolving drug tenecteplase. It aims to see how well the drug works and how safe it is in everyday hospital care in China.
This trial tests if the clot-busting drug tenecteplase can help people with a moderate to severe stroke when given 24 to 72 hours after symptoms began. It aims to see if this later treatment window can improve recovery and reduce disability.
Hear when a new Stroke, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.